BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32874054)

  • 1. Accelerating the elimination of hepatitis C in Kuwait: An expert opinion.
    Hasan F; Alfadhli A; Al-Gharabally A; Alkhaldi M; Colombo M; Lazarus JV
    World J Gastroenterol; 2020 Aug; 26(30):4415-4427. PubMed ID: 32874054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Securing sustainable funding for viral hepatitis elimination plans.
    Hatzakis A; Lazarus JV; Cholongitas E; Baptista-Leite R; Boucher C; Busoi CS; Deuffic-Burban S; Chhatwal J; Esmat G; Hutchinson S; Malliori MM; Maticic M; Mozalevskis A; Negro F; Papandreou GA; Papatheodoridis GV; Peck-Radosavljevic M; Razavi H; Reic T; Schatz E; Tozun N; Younossi Z; Manns MP
    Liver Int; 2020 Feb; 40(2):260-270. PubMed ID: 31808281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global reporting of progress towards elimination of hepatitis B and hepatitis C.
    Cui F; Blach S; Manzengo Mingiedi C; Gonzalez MA; Sabry Alaama A; Mozalevskis A; Séguy N; Rewari BB; Chan PL; Le LV; Doherty M; Luhmann N; Easterbrook P; Dirac M; de Martel C; Nayagam S; Hallett TB; Vickerman P; Razavi H; Lesi O; Low-Beer D
    Lancet Gastroenterol Hepatol; 2023 Apr; 8(4):332-342. PubMed ID: 36764320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
    Papatheodoridis GV; Hatzakis A; Cholongitas E; Baptista-Leite R; Baskozos I; Chhatwal J; Colombo M; Cortez-Pinto H; Craxi A; Goldberg D; Gore C; Kautz A; Lazarus JV; Mendão L; Peck-Radosavljevic M; Razavi H; Schatz E; Tözün N; van Damme P; Wedemeyer H; Yazdanpanah Y; Zuure F; Manns MP
    J Viral Hepat; 2018 Mar; 25 Suppl 1():6-17. PubMed ID: 29508946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
    Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
    World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key Role of Multidisciplinary Collaboration towards Global Elimination of HCV Infection.
    Krekulova L; Oktabec Z; Riley LW
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress on global hepatitis elimination targets.
    Waheed Y
    World J Gastroenterol; 2021 Dec; 27(47):8199-8200. PubMed ID: 35068864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis C.
    Sulkowski M; Cheng WH; Marx S; Sanchez Gonzalez Y; Strezewski J; Reau N
    Adv Ther; 2021 Jan; 38(1):423-440. PubMed ID: 33145648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus micro-elimination: Where do we stand?
    Mangia A; Cotugno R; Cocomazzi G; Squillante MM; Piazzolla V
    World J Gastroenterol; 2021 Apr; 27(16):1728-1737. PubMed ID: 33967553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards hepatitis C virus elimination in high-income countries: An updated analysis.
    Gamkrelidze I; Pawlotsky JM; Lazarus JV; Feld JJ; Zeuzem S; Bao Y; Gabriela Pires Dos Santos A; Sanchez Gonzalez Y; Razavi H
    Liver Int; 2021 Mar; 41(3):456-463. PubMed ID: 33389788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
    European Union HCV Collaborators
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy for the Elimination of Hepatitis C in Cantabria.
    Crespo J; Tejerina Puente A; Cuadrado A; Llerena S; Cabezas J;
    Rev Esp Enferm Dig; 2020 Jul; 112(7):565-570. PubMed ID: 32543873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy.
    Lazarus JV; Picchio CA; Guy D; Aleman S; James C; Nava FA; Øvrehus A; Turnes J; Ward JW; Ustianowski A
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101564. PubMed ID: 33740477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global timing of hepatitis C virus elimination in high-income countries.
    Razavi H; Sanchez Gonzalez Y; Yuen C; Cornberg M
    Liver Int; 2020 Mar; 40(3):522-529. PubMed ID: 31815353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro-elimination of hepatitis C virus.
    Hollande C; Parlati L; Pol S
    Liver Int; 2020 Feb; 40 Suppl 1():67-71. PubMed ID: 32077601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all.
    Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C;
    Int J Drug Policy; 2019 Oct; 72():1-10. PubMed ID: 31345644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is global elimination of HCV realistic?
    Calvaruso V; Petta S; Craxì A
    Liver Int; 2018 Feb; 38 Suppl 1():40-46. PubMed ID: 29427499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic.
    Bajis S; Applegate TL; Grebely J; Matthews GV; Dore GJ
    J Infect Dis; 2020 Nov; 222(Suppl 9):S758-S772. PubMed ID: 33245354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Securing wider EU commitment to the elimination of hepatitis C virus.
    Wedemeyer H; Tergast TL; Lazarus JV; Razavi H; Bakoyannis K; Baptista-Leite R; Bartoli M; Bruggmann P; Buşoi CS; Buti M; Carballo M; Castera L; Colombo M; Coutinho RS; Dadon Y; Esmat G; Esteban R; Farran JC; Gillyon-Powell M; Goldberg D; Hutchinson S; Janssen HLA; Kalamitsis G; Kondili LA; Lambert JS; Marinho RT; Maticic M; Patricello A; Peck-Radosavljevic M; Pol S; Poljak M; Pop C; Sokol T; Sypsa V; Tözün N; Younossi Z; Aghemo A; Papatheodoridis GV; Hatzakis A
    Liver Int; 2023 Feb; 43(2):276-291. PubMed ID: 36196744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.